Dissemination and prevalence of polymyxin-resistant bacteria of clinical and environmental origin
Polymyxins were discovered in the 1940s and were used to treat infections caused by gram-negative bacteria. These molecules act by destroying the cell membrane through the destabilization of phospholipids and lipopolysaccharides (LPS). Due to adverse effects, such as nephrotoxicity and neurotoxicity...
| Autores: | , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2022 |
| País: | Brasil |
| Institución: | Universidade Federal de Itajubá (UNIFEI) |
| Repositorio: | Research, Society and Development |
| Idioma: | inglés |
| OAI Identifier: | oai:ojs.pkp.sfu.ca:article/34996 |
| Acceso en línea: | https://rsdjournal.org/index.php/rsd/article/view/34996 |
| Access Level: | acceso abierto |
| Palabra clave: | Bacillus polymyxa Colistina Resistencia bacteriana Salud pública. Colistin Bacterial resistance Public health. Resistência bacteriana Saúde pública. |
| id |
BR_e36d71aaf5be33e22f35fce9ec0082a0 |
|---|---|
| oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/34996 |
| network_acronym_str |
BR |
| network_name_str |
Brasil |
| repository_id_str |
|
| dc.title.none.fl_str_mv |
Dissemination and prevalence of polymyxin-resistant bacteria of clinical and environmental origin Diseminación y prevalencia de bacterias resistentes a la polimixina de origen clínico y ambiental Disseminação e prevalência de bactérias resistentes à polimixina de origem clínica e ambiental |
| title |
Dissemination and prevalence of polymyxin-resistant bacteria of clinical and environmental origin |
| spellingShingle |
Dissemination and prevalence of polymyxin-resistant bacteria of clinical and environmental origin Costa Júnior, Sérgio Dias da Bacillus polymyxa Colistina Resistencia bacteriana Salud pública. Bacillus polymyxa Colistin Bacterial resistance Public health. Bacillus polymyxa Colistina Resistência bacteriana Saúde pública. |
| title_short |
Dissemination and prevalence of polymyxin-resistant bacteria of clinical and environmental origin |
| title_full |
Dissemination and prevalence of polymyxin-resistant bacteria of clinical and environmental origin |
| title_fullStr |
Dissemination and prevalence of polymyxin-resistant bacteria of clinical and environmental origin |
| title_full_unstemmed |
Dissemination and prevalence of polymyxin-resistant bacteria of clinical and environmental origin |
| title_sort |
Dissemination and prevalence of polymyxin-resistant bacteria of clinical and environmental origin |
| dc.creator.none.fl_str_mv |
Costa Júnior, Sérgio Dias da Campos, Luís André de Almeida Cavalcanti, Iago Dillion Lima Costa, Jainaldo Alves da Ferreira, Gustavo Ramos Salles Silva, Jaqueline dos Santos Silva, Sivoneide Maria da Oliveira, Maria Betânia Melo de |
| author |
Costa Júnior, Sérgio Dias da |
| author_facet |
Costa Júnior, Sérgio Dias da Campos, Luís André de Almeida Cavalcanti, Iago Dillion Lima Costa, Jainaldo Alves da Ferreira, Gustavo Ramos Salles Silva, Jaqueline dos Santos Silva, Sivoneide Maria da Oliveira, Maria Betânia Melo de |
| author_role |
author |
| author2 |
Campos, Luís André de Almeida Cavalcanti, Iago Dillion Lima Costa, Jainaldo Alves da Ferreira, Gustavo Ramos Salles Silva, Jaqueline dos Santos Silva, Sivoneide Maria da Oliveira, Maria Betânia Melo de |
| author2_role |
author author author author author author author |
| dc.subject.por.fl_str_mv |
Bacillus polymyxa Colistina Resistencia bacteriana Salud pública. Bacillus polymyxa Colistin Bacterial resistance Public health. Bacillus polymyxa Colistina Resistência bacteriana Saúde pública. |
| topic |
Bacillus polymyxa Colistina Resistencia bacteriana Salud pública. Bacillus polymyxa Colistin Bacterial resistance Public health. Bacillus polymyxa Colistina Resistência bacteriana Saúde pública. |
| description |
Polymyxins were discovered in the 1940s and were used to treat infections caused by gram-negative bacteria. These molecules act by destroying the cell membrane through the destabilization of phospholipids and lipopolysaccharides (LPS). Due to adverse effects, such as nephrotoxicity and neurotoxicity, this class had seen limited use. However, with the evolution of antimicrobial resistance to commercial drugs, the use of polymyxins has resumed, and over time, strains resistant to this drug have been observed. Currently, resistant bacteria this antimicrobial are found in hospital environments, and non-anthropized environments. This occurrence constitutes a global human and environmental health problem that is of concern to the population, health professionals, and researchers. Thus, this review was conducted with the objective of describing the mechanisms and the occurrence of bacterial resistance to polymyxins, and to demonstrate the relationship between multi-resistant strains of clinical and environmental origins. |
| publishDate |
2022 |
| dc.date.none.fl_str_mv |
2022-09-29 |
| dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/34996 10.33448/rsd-v11i13.34996 |
| url |
https://rsdjournal.org/index.php/rsd/article/view/34996 |
| identifier_str_mv |
10.33448/rsd-v11i13.34996 |
| dc.language.iso.fl_str_mv |
eng |
| language |
eng |
| dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/34996/29516 |
| dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Research, Society and Development |
| publisher.none.fl_str_mv |
Research, Society and Development |
| dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 11 No. 13; e94111334996 Research, Society and Development; Vol. 11 Núm. 13; e94111334996 Research, Society and Development; v. 11 n. 13; e94111334996 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
| instname_str |
Universidade Federal de Itajubá (UNIFEI) |
| instacron_str |
UNIFEI |
| institution |
UNIFEI |
| reponame_str |
Research, Society and Development |
| collection |
Research, Society and Development |
| repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
| repository.mail.fl_str_mv |
rsd.articles@gmail.com |
| _version_ |
1853659898489864192 |
| spelling |
Dissemination and prevalence of polymyxin-resistant bacteria of clinical and environmental originDiseminación y prevalencia de bacterias resistentes a la polimixina de origen clínico y ambientalDisseminação e prevalência de bactérias resistentes à polimixina de origem clínica e ambientalBacillus polymyxaColistinaResistencia bacterianaSalud pública.Bacillus polymyxaColistinBacterial resistancePublic health.Bacillus polymyxaColistinaResistência bacterianaSaúde pública.Polymyxins were discovered in the 1940s and were used to treat infections caused by gram-negative bacteria. These molecules act by destroying the cell membrane through the destabilization of phospholipids and lipopolysaccharides (LPS). Due to adverse effects, such as nephrotoxicity and neurotoxicity, this class had seen limited use. However, with the evolution of antimicrobial resistance to commercial drugs, the use of polymyxins has resumed, and over time, strains resistant to this drug have been observed. Currently, resistant bacteria this antimicrobial are found in hospital environments, and non-anthropized environments. This occurrence constitutes a global human and environmental health problem that is of concern to the population, health professionals, and researchers. Thus, this review was conducted with the objective of describing the mechanisms and the occurrence of bacterial resistance to polymyxins, and to demonstrate the relationship between multi-resistant strains of clinical and environmental origins.Las polimixinas se descubrieron en la década de 1940 y se usaron para tratar infecciones causadas por bacterias gramnegativas. Estas moléculas actúan destruyendo la membrana celular mediante la desestabilización de los fosfolípidos y lipopolisacáridos (LPS). Debido a los efectos adversos, como la nefrotoxicidad y la neurotoxicidad, esta clase ha tenido un uso limitado. Sin embargo, con la evolución de la resistencia antimicrobiana a los fármacos comerciales, se ha retomado el uso de polimixinas y con el tiempo se han observado cepas resistentes a este fármaco. Actualmente, las bacterias resistentes a este antimicrobiano se encuentran en ambientes hospitalarios y ambientes no antropizados. Este hecho constituye un problema mundial de salud humana y ambiental que preocupa a la población, profesionales de la salud e investigadores. Por lo tanto, esta revisión se realizó con el objetivo de describir los mecanismos y la aparición de resistencia bacteriana a las polimixinas, y demostrar la relación entre cepas multirresistentes de origen clínico y ambiental.As polimixinas foram descobertas na década de 1940 e eram usadas para tratar infecções causadas por bactérias gram-negativas. Essas moléculas atuam destruindo a membrana celular através da desestabilização de fosfolipídios e lipopolissacarídeos (LPS). Devido a efeitos adversos, como nefrotoxicidade e neurotoxicidade, essa classe teve o uso limitado. No entanto, com a evolução da resistência antimicrobiana aos medicamentos comerciais, o uso de polimixinas foi retomado e, com o passar do tempo, foram observadas cepas resistentes a esses medicamentos. Atualmente, bactérias resistentes a estes antimicrobianos, são encontradas em ambientes hospitalares e não antropizados. Essa ocorrência constitui um problema global de saúde humana e ambiental que preocupa a população, profissionais de saúde e pesquisadores. Assim, esta revisão foi realizada com o objetivo de descrever os mecanismos e a ocorrência de resistência bacteriana às polimixinas, e demonstrar a relação entre cepas multirresistentes de origem clínica e ambiental.Research, Society and Development2022-09-29info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/3499610.33448/rsd-v11i13.34996Research, Society and Development; Vol. 11 No. 13; e94111334996Research, Society and Development; Vol. 11 Núm. 13; e94111334996Research, Society and Development; v. 11 n. 13; e941113349962525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIenghttps://rsdjournal.org/index.php/rsd/article/view/34996/29516Copyright (c) 2022 Sérgio Dias da Costa Júnior; Luís André de Almeida Campos; Iago Dillion Lima Cavalcanti; Jainaldo Alves da Costa; Gustavo Ramos Salles Ferreira; Jaqueline dos Santos Silva; Sivoneide Maria da Silva; Maria Betânia Melo de Oliveirahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessCosta Júnior, Sérgio Dias da Campos, Luís André de AlmeidaCavalcanti, Iago Dillion Lima Costa, Jainaldo Alves da Ferreira, Gustavo Ramos Salles Silva, Jaqueline dos Santos Silva, Sivoneide Maria da Oliveira, Maria Betânia Melo de2022-10-17T13:43:46Zoai:ojs.pkp.sfu.ca:article/34996Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:50:04.485711Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
| score |
15,300724 |